Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands

被引:9
|
作者
van der Meulen, Matthijs [1 ,2 ]
Bromberg, Jacoline E. C. [1 ]
Nijland, Marcel [3 ]
Visser, Otto [4 ]
Doorduijn, Jeanette K. [5 ]
Dinmohamed, Avinash G. [5 ,6 ,7 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Neurooncol, Rotterdam, Netherlands
[2] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands
[3] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[4] Netherlands Comprehens Canc Org IKNL, Dept Registrat, Utrecht, Netherlands
[5] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
[6] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[7] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Publ Hlth, Rotterdam, Netherlands
关键词
PRIMARY CNS LYMPHOMA; WHOLE-BRAIN RADIOTHERAPY; INTERNATIONAL EXTRANODAL LYMPHOMA; HIGH-DOSE METHOTREXATE;
D O I
10.3324/haematol.2020.247536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:597 / 600
页数:4
相关论文
共 50 条
  • [1] PRIMARY THERAPY AND SURVIVAL IN OVER 70-YEAR-OLD PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS
    van der Meulen, M.
    Bromberg, J. E. C.
    Visser, O.
    Doorduijn, J. K.
    Dinmohamed, A. G.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 21 - 21
  • [2] Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
    Dinmohamed, Avinash G.
    van der Meulen, Matthijs
    Visser, Otto
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    [J]. NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [3] Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015
    M van der Meulen
    A G Dinmohamed
    O Visser
    J K Doorduijn
    J E C Bromberg
    [J]. Leukemia, 2017, 31 : 1822 - 1825
  • [4] Survival prediction and conditional survival of primary central nervous system lymphoma: A population-based study
    Ke, Boxi
    Cai, Xueli
    Peng, Xiao
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 93 : 188 - 194
  • [5] Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study
    Shan, Yudong
    Hu, Yilan
    [J]. DISEASE MARKERS, 2018, 2018
  • [6] Improved survival in primary central nervous system lymphoma up to age 70 only: A population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015
    van der Meulen, M.
    Dinmohammed, A.
    Visser, O.
    Doorduijn, J.
    Bromberg, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 50 - 51
  • [7] IMPROVED SURVIVAL IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA UP TO AGE 70 ONLY: A POPULATION-BASED STUDY ON INCIDENCE, PRIMARY TREATMENT AND SURVIVAL IN THE NETHERLANDS, 1989-2015
    Dinmohamed, A.
    van der Meulen, M.
    Visser, O.
    Doorduijn, J.
    Bromberg, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 57 - 58
  • [8] Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015
    van der Meulen, M.
    Dinmohamed, A. G.
    Visser, O.
    Doorduijn, J. K.
    Bromberg, J. E. C.
    [J]. LEUKEMIA, 2017, 31 (08) : 1822 - 1825
  • [9] Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989–2017
    Julia Driessen
    Otto Visser
    Josée M. Zijlstra
    Pieternella J. Lugtenburg
    Wouter J. Plattel
    Marie José Kersten
    Avinash G. Dinmohamed
    [J]. Leukemia, 2021, 35 : 494 - 505
  • [10] Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018
    Issa, D. E.
    Seefat, R. L.
    Visser, O.
    Zweegman, S.
    Lugtenburg, P. J.
    Dinmohamed, A. G.
    Chamuleau, M. E. D.
    [J]. BLOOD, 2021, 137 (20) : 2848 - 2851